<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fremuth LE</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Assisi Foundation of Memphis Inc</funding><funding>American Lebanese Syrian Associated Charities</funding><funding>NINDS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>115204</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11874873</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(1)</volume><pubmed_abstract>Neuraminidase 1 (NEU1) cleaves terminal sialic acids from sialoglycoproteins in endolysosomes and at the plasma membrane. As such, NEU1 regulates immune cells, primarily those of the monocytic lineage. Here, we examine how Neu1 influences microglia by modulating the sialylation of full-length Trem2 (Trem2-FL), a multifunctional receptor that regulates microglial survival, phagocytosis, and cytokine production. When Neu1 is deficient/downregulated, Trem2-FL remains sialylated, accumulates intracellularly, and is excessively cleaved into a C-terminal fragment (Trem2-CTF) and an extracellular soluble domain (sTrem2), enhancing their signaling capacities. Sialylated Trem2-FL (Sia-Trem2-FL) does not hinder Trem2-FL-DAP12-Syk complex assembly but impairs signal transduction through Syk, ultimate</pubmed_abstract><journal>Cell reports</journal><pubmed_title>Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation.</pubmed_title><pmcid>PMC11874873</pmcid><funding_grant_id>R01 GM104981</funding_grant_id><funding_grant_id>P30 CA021765</funding_grant_id><funding_grant_id>RF1 NS123174</funding_grant_id><pubmed_authors>Fremuth LE</pubmed_authors><pubmed_authors>Annunziata I</pubmed_authors><pubmed_authors>Hu H</pubmed_authors><pubmed_authors>Weesner JA</pubmed_authors><pubmed_authors>van de Vlekkert D</pubmed_authors><pubmed_authors>Alessandra d'Azzo</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation.</name><description>Neuraminidase 1 (NEU1) cleaves terminal sialic acids from sialoglycoproteins in endolysosomes and at the plasma membrane. As such, NEU1 regulates immune cells, primarily those of the monocytic lineage. Here, we examine how Neu1 influences microglia by modulating the sialylation of full-length Trem2 (Trem2-FL), a multifunctional receptor that regulates microglial survival, phagocytosis, and cytokine production. When Neu1 is deficient/downregulated, Trem2-FL remains sialylated, accumulates intracellularly, and is excessively cleaved into a C-terminal fragment (Trem2-CTF) and an extracellular soluble domain (sTrem2), enhancing their signaling capacities. Sialylated Trem2-FL (Sia-Trem2-FL) does not hinder Trem2-FL-DAP12-Syk complex assembly but impairs signal transduction through Syk, ultimate</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-01T10:39:51.413Z</modification><creation>2025-04-05T11:18:23.603Z</creation></dates><accession>S-EPMC11874873</accession><cross_references><pubmed>39817909</pubmed><doi>10.1016/j.celrep.2024.115204</doi></cross_references></HashMap>